Archives

by in
Entry Author Date Location
Talyst Raises $8M, MDRNA Sells Stock for $10.5M, Sonosite Buys CardioDynamics & More Seattle-Area Deals News 06/16/09 Seattle
Dendreon Resists Urge to Sell Out, NanoString Nabs $30M, VC Firm Cashes Out on OncoGenex, & More Seattle-Area Life Sciences News 06/11/09 Seattle
MDRNA Raises $10.5M 06/10/09 Seattle
MDRNA Obtains $10,500,000 New Funding 06/10/09 Seattle
MDRNA Nasal Spray Gets FDA Nod 06/09/09 Seattle
Vulcan’s Biotech Windfall, Tekmira Tackles RNAi Delivery, The $1,000 Genome Debate, & More Seattle-Area Life Sciences News 05/28/09 Seattle
MDRNA Shrinks Board of Directors 05/21/09 Seattle
Swype Scores $1.3M, Onehub Raises $600K, Genzyme Comes to Town, & More Seattle-Area Deals News 04/07/09 Seattle
Genzyme Enters Seattle Hub, Oncothyreon Bets on Cancer Drugs, Pathway Nabs $40M, & More Seattle-Area Life Sciences News 04/02/09 Seattle
MDRNA Sells Osteoporosis Drug 04/01/09 Seattle
Obama Stimulates UW, Public Biotechs Run Low on Cash, Healionics Ships Glaucoma Product & More Seattle-Area Life Sciences News 03/26/09 Seattle
The Northwest Biotech Survival Index 2: Companies Scraping By in Downturn 03/25/09 Seattle
Intellectual Ventures Inks India Deal, Ontela Teams with T-Mobile, MDRNA Nabs $7.25M, & More Seattle-Area Deals News 03/24/09 Seattle
MDRNA Nabs $7.25M From Novartis 03/23/09 Seattle
MDRNA Secures $7,250,000 Series D Financing Round 03/23/09 Seattle
PivotLink Lands $10M, Founder’s Funds Frugal, Earth Class Mail Signs Swiss Post, & More Seattle-Area Deals News 02/17/09 Seattle
MDRNA Cuts Deal With Roche 02/13/09 Seattle
Sticking it to the VC Man: Johnny Stine Builds Biotech Startup on a Shoestring 02/06/09 Seattle
Pathway Medical Gets Traction, Ekos Raises $12.5M, ZymoGenetics Sales Boss Departs, & More Seattle-Area Life Sciences News 02/05/09 Seattle
MDRNA Gets $1M Milestone 02/03/09 Seattle
Seattle Genetics Raises Dough, Trubion Feels Fallout of Pfizer Deal, Novo Sets Up Shop, & More Seattle-Area Life Sciences News 01/29/09 Seattle
MDRNA Cuts Executive Pay, Freezes Salaries as Cash Runs Out 01/23/09 Seattle
MDRNA Gets Tentative FDA Approval 12/15/08 Seattle
Biotech Survival Index: Cash Running Low at Seattle Life Sciences Companies 11/13/08 Seattle
Alnylam–Isis Venture Regulus, Leader in MicroRNA Drugs, Aspires to Create New Paradigm of Treatments 10/24/08 San Diego
MDRNA Cuts 23 Jobs, Mostly in Nasal Delivery Business 08/05/08 Seattle
Page 2 of 2 « previous page
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.